Product Program year 2020 Source: CMS Open Payments

ZolpiMist

Drug Urology

NDC 58407-510-30

Open in the dashboard

General payments

$2,465

160 payments

Research payments

$0

0 payments

Through program year 2020, $2,465 in general payments and $0 in research payments were reported against ZolpiMist (Urology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $529 35
2019 General $1,936 125

Breakdown

Who paid General payments · program years 2019–2020
  1. Aytu BioScience, Inc $2,465 160 payments
Top recipients General payments · program year 2020
  1. Ericka Flood Family Medicine · Gonzales, LA $52 10% · 4 payments
  2. Roberto Ortiz Infectious Disease · Orlando, FL $47 9% · 2 payments
  3. John Anton Internal Medicine · Livingston, NJ $46 9% · 5 payments
  4. Lisa Whims Squires Pulmonary Disease · Clearwater, FL $25 5% · 1 payment
  5. Edward Allegra Red Bank, NJ $25 5% · 2 payments

The top 5 of 26 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Family Medicine $216 43% · 12 practitioners
  2. Internal Medicine $162 32% · 8 practitioners
  3. Infectious Disease Internal Medicine $47 9% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $44 9% · 2 practitioners
  5. Adolescent Medicine Internal Medicine $19 4% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $176 33% · 8 recipients
  2. Louisiana $171 32% · 9 recipients
  3. New Jersey $84 16% · 3 recipients
  4. Connecticut $62 12% · 4 recipients
  5. New York $36 7% · 2 recipients

Each share is of general payments naming this product in 2020 where a state was reported.

160 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record